-+ 0.00%
-+ 0.00%
-+ 0.00%

MILESTONE RECEIVES FDA APPROVAL OF CARDAMYST™ (ETRIPAMIL) AS FIRST AND ONLY SELF-ADMINISTERED NASAL SPRAY FOR ADULTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT)

路透·12/13/2025 01:00:00

登錄查看新聞詳情